Biomea Fusion, Inc.
BMEA • NASDAQ
Biomea Fusion, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael J. Hitchcock, with a market cap of $80.6M.
CEOMichael J. Hitchcock
Market Cap$80.6M
Biotechnology
Healthcare
Employees110.0
Websitebiomeafusion.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Biomea Fusion, Inc.
Date
Monday, May 4, 2026 (in 3 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.19
Earnings History
Past 11 earnings reports for Biomea Fusion, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 4, 2025 | Q3 2025 | -$0.27Est: -$0.28 | +3.6% | - | — |  10-Q |
| Aug 5, 2025 | Q2 2025 | -$0.51Est: -$0.54 | +5.6% | - | — | 10-Q |
| May 5, 2025 | Q1 2025 | -$0.80Est: -$0.60 | -33.3% | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.81Est: -$0.93 | +12.9% | - | — | 10-K |
| Oct 29, 2024 | Q3 2024 | -$0.91Est: -$1.00 | +9.0% | - | — | 10-Q |
| Jul 31, 2024 | Q2 2024 | -$1.03Est: -$1.07 | +3.7% | - | — | 10-Q |
| May 2, 2024 | Q1 2024 | -$1.09Est: -$0.99 | -10.1% | - | — | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$0.98Est: -$0.85 | -15.3% | - | — | 10-K |
| Oct 30, 2023 | Q3 2023 | -$0.80Est: -$0.82 | +2.4% | - | — | 10-Q |
| Jul 31, 2023 | Q2 2023 | -$0.70Est: -$0.87 | +19.5% | - | — | 10-Q |
| May 2, 2023 | Q1 2023 | -$0.98Est: -$0.81 | -21.0% | - | — | — |